#cparse("/super/config/super.config.vm") #cparse("${superIncludes}/super.before-doctype.fhtml")
#cparse("${superIncludes}/super.head-top.fhtml")![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Nature Biotechnology and Nature Reviews Drug Discovery are proud to present a special focus on Antivirals in December 2007. The global impact of viral infection, the development of resistance to current drugs, and the continuing threat of global pandemics due to the emergence of new viruses translate into unique scientific and strategic challenges for antiviral drug discovery and development. A concerted effort between academia, the biotech and pharmaceutical industries is needed to tackle these challenges. Incorporating the perspectives of leaders in the field, this print and web focus comprehensively summarizes the science and business of antiviral drug R&D, highlighting innovative approaches and lessons learned from decades of antiviral drug development, as well as identifying key issues for future antiviral drug discovery and potential solutions. To access this special focus visit: www.nature.com/focus/antivirals |
![]() |
![]() |
Nature Publishing Group | 75 Varick St Fl 9 | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire © 2007 Nature Publishing Group |
![]() |